<DOC>
	<DOCNO>NCT01080612</DOCNO>
	<brief_summary>The purpose study ( 1 ) evaluate effect caloric intake pharmacokinetics single dose 330 mg pregabalin control release tablet relative 300 mg pregabalin immediate release capsule administer fast ( 2 ) determine safety tolerability single dose 330 mg pregabalin control release formulation administer follow various size caloric meal 300 mg pregabalin immediate release capsule administer fast .</brief_summary>
	<brief_title>A Study To Assess The Pharmacokinetics , Safety , And Tolerability Of A Pregabalin Controlled Release Formulation Administered Following Various Sized Caloric Meals As Compared To The Pregabalin Immediate Release Formulation</brief_title>
	<detailed_description>To assess single dose pharmacokinetics , safety , tolerability pregabalin control release formulation follow various size caloric meal relative immediate release formulation .</detailed_description>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Healthy male female Between age 18 55 year , inclusive Body Mass Index ( BMI ) 17.5 30.5 kg/m2 Illicit drug use Pregnant nursing female Females childbearing potential unwilling unable use acceptable method contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>pregabalin</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>bioavailability</keyword>
</DOC>